Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 51 of 100

  • Novartis drug prices trumpHealth

    Drug Giant Novartis Is Temporarily Backing Off Price Increases Following Trump Pressure

    By
  • Health

    Brainstorm Health: Fortune 40 Under 40, Drug Prices, Liver Disease Deaths

    By
  • Gym tax breakHealth

    You Could Soon Get a Tax Break for Going to the Gym—But Should You?

    By
  • Health

    Brainstorm Health: Melanoma Blood Test, When Milk Isn’t Milk, Brexit Drug Stockpiling

    By
  • Melanoma blood testHealth

    Why a Melanoma Blood Test Would Be Such a Big Deal

    By
  • Health

    Brainstorm Health: Digital Media and ADHD, Johnson & Johnson Shares, Liver Cancer Deaths

    By
  • Health

    Brainstorm Health: Prime Day FOMO, Blood Pressure Drug Recall, Unnecessary Antibiotics

    By
  • Health

    Brainstorm Health: Gym Tax Deduction, Zogenix Stock, J&J Verdict

    By
  • CRISPR CancerHealth

    Scientists Just Found a Novel, Cheap Way to Use CRISPR Gene Editing to Fight Cancer

    By
  • Health

    Brainstorm Health: Parker Institute CRISPR Breakthrough, Pfizer Reorganization, Gym Tax Deductions

    By
  • Costco-food-court-Polish-dogHealth

    Costco’s Food Court Is Getting Rid of the Polish Dog—It’s Not Even the Most Unhealthy Thing on the Menu

    By
  • US-POLITICS-TRUMPHealth

    3 Key Lessons From Trump’s Drug Price Feud With Pfizer

    By
  • American HealthcareHealth

    The Critical Group We’re Ignoring in the Opioid Crisis

    By
  • Health

    Brainstorm Health: Pain Patients and Opioids, Gene Editing Cholesterol, Doctor Burnout

    By
  • BioGen AlzheimersHealth

    Biogen’s Stock Is Soaring Because of Its Experimental Alzheimer’s Drug — But Some Are Urging Caution

    By